1
|
Martel-Pelletier J, Barr AJ, Cicuttini FM,
Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl
AJ and Pelletier JP: Osteoarthritis. Nat Rev Dis Primers.
2(16072)2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Disease GBD, Injury I and Prevalence C:
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators.
Global, regional, and national incidence, prevalence, and years
lived with disability for 310 diseases and injuries, 1990-2015: A
systematic analysis for the Global Burden of Disease Study 2015.
Lancet. 388:1545–1602. 2016.PubMed/NCBI View Article : Google Scholar
|
3
|
Sokolove J and Lepus CM: Role of
inflammation in the pathogenesis of osteoarthritis: Latest findings
and interpretations. Ther Adv Musculoskelet Dis. 5:77–94.
2013.PubMed/NCBI View Article : Google Scholar
|
4
|
Swagerty DL Jr and Hellinger D:
Radiographic assessment of osteoarthritis. Am Fam Physician.
64:279–286. 2001.PubMed/NCBI
|
5
|
Kohn MD, Sassoon AA and Fernando ND:
Classifications in Brief: Kellgren-Lawrence classification of
osteoarthritis. Clin Orthop Relat Res. 474:1886–1893.
2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Hurley M, Dickson K, Hallett R, Grant R,
Hauari H, Walsh N, Stansfield C and Oliver S: Exercise
interventions and patient beliefs for people with hip, knee or hip
and knee osteoarthritis: A mixed methods review. Cochrane Database
Syst Rev. 4(CD010842)2018.PubMed/NCBI View Article : Google Scholar
|
7
|
Bultink IE and Lems WF: Osteoarthritis and
osteoporosis: What is the overlap? Curr Rheumatol Rep.
15(328)2013.PubMed/NCBI View Article : Google Scholar
|
8
|
Pouresmaeili F, Kamalidehghan B, Kamarehei
M and Goh YM: A comprehensive overview on osteoporosis and its risk
factors. Ther Clin Risk Manag. 14:2029–2049. 2018.PubMed/NCBI View Article : Google Scholar
|
9
|
Sözen T, Özışık L and Başaran NC: An
overview and management of osteoporosis. Eur J Rheumatol. 4:46–56.
2017.PubMed/NCBI View Article : Google Scholar
|
10
|
Nazrun AS, Tzar MN, Mokhtar SA and Mohamed
IN: A systematic review of the outcomes of osteoporotic fracture
patients after hospital discharge: Morbidity, subsequent fractures,
and mortality. Ther Clin Risk Manag. 10:937–948. 2014.PubMed/NCBI View Article : Google Scholar
|
11
|
Dhital R, Lynn T, Tachamo N and Poudel DR:
The trend of osteoporosis and osteoporotic fragility fractures in
inpatients: Results from a national database. J Community Hosp
Intern Med Perspect. 9:211–214. 2019.PubMed/NCBI View Article : Google Scholar
|
12
|
Loeser RF: The role of aging in the
development of osteoarthritis. Trans Am Clin Climatol Assoc.
128:44–54. 2017.PubMed/NCBI
|
13
|
Palo N, Chandel SS, Dash SK, Arora G,
Kumar M and Biswal MR: Effects of osteoarthritis on quality of life
in elderly population of Bhubaneswar, India: A prospective
multicenter screening and therapeutic study of 2854 patients.
Geriatr Orthop Surg Rehabil. 6:269–275. 2015.PubMed/NCBI View Article : Google Scholar
|
14
|
Lorenzo P, Aspberg A, Saxne T and
Önnerfjord P: Quantification of cartilage oligomeric matrix protein
(COMP) and a COMP neoepitope in synovial fluid of patients with
different joint disorders by novel automated assays. Osteoarthritis
Cartilage. 25:1436–1442. 2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Fernández-Puente P, Calamia V,
González-Rodríguez L, Lourido L, Camacho-Encina M, Oreiro N,
Ruiz-Romero C and Blanco FJ: Multiplexed mass spectrometry
monitoring of biomarker candidates for osteoarthritis. J
Proteomics. 152:216–225. 2017.PubMed/NCBI View Article : Google Scholar
|
16
|
van der Meijden OA, Gaskill TR and Millett
PJ: Glenohumeral joint preservation: A review of management options
for young, active patients with osteoarthritis. Adv Orthop.
2012(160923)2012.PubMed/NCBI View Article : Google Scholar
|
17
|
Sergé A: The molecular architecture of
cell adhesion: Dynamic remodeling revealed by videonanoscopy. Front
Cell Dev Biol. 4(36)2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Liu F, Wang X, Zhang X, Ren C and Xin J:
Role of serum cartilage oligomeric matrix protein (COMP) in the
diagnosis of rheumatoid arthritis (RA): A case-control study. J Int
Med Res. 44:940–949. 2016.PubMed/NCBI View Article : Google Scholar
|
19
|
Samali A, Fulda S, Gorman AM, Hori O and
Srinivasula SM: Cell stress and cell death. Int J Cell Biol.
2010(245803)2010.PubMed/NCBI View Article : Google Scholar
|
20
|
Green DR and Llambi F: Cell death
signaling. Cold Spring Harb Perspect Biol.
7(a006080)2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Kim YL, Im YJ, Ha NC and Im DS: Albumin
inhibits cytotoxic activity of lysophosphatidylcholine by direct
binding. Prostaglandins Other Lipid Mediat. 83:130–138.
2007.PubMed/NCBI View Article : Google Scholar
|
22
|
Kothari P, Johnson C, Sandone C, Iglesias
PA and Robinson DN: How the mechanobiome drives cell behavior,
viewed through the lens of control theory. J Cell Sci.
132(jcs234476)2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Mateos J, De la Fuente A,
Lesende-Rodriguez I, Fernández-Pernas P, Arufe MC and Blanco FJ:
Lamin A deregulation in human mesenchymal stem cells promotes an
impairment in their chondrogenic potential and imbalance in their
response to oxidative stress. Stem Cell Res (Amst). 11:1137–1148.
2013.PubMed/NCBI View Article : Google Scholar
|
24
|
Attur M, Ben-Artzi A, Yang Q, Al-Mussawir
HE, Worman HJ, Palmer G and Abramson SB: Perturbation of nuclear
lamin A causes cell death in chondrocytes. Arthritis Rheum.
64:1940–1949. 2012.PubMed/NCBI View Article : Google Scholar
|
25
|
Stephan JP, Roberts PE, Bald L, Lee J, Gu
Q, Devaux B and Mather JP: Selective cloning of cell surface
proteins involved in organ development: Epithelial glycoprotein is
involved in normal epithelial differentiation. Endocrinology.
140:5841–5854. 1999.PubMed/NCBI View Article : Google Scholar
|
26
|
Huang Z, Wang X and Chen D: Signal
proteins involved in myogenic stem cells differentiation. Curr
Protein Pept Sci. 18:571–578. 2017.PubMed/NCBI View Article : Google Scholar
|
27
|
Oh JE, Freilinger A, Gelpi E, Pollak A,
Hengstschläger M and Lubec G: Proteins involved in neuronal
differentiation of neuroblastoma cell line N1E-115.
Electrophoresis. 28:2009–2017. 2007.PubMed/NCBI View Article : Google Scholar
|
28
|
Grassel S and Aszodi A: Osteoarthritis and
cartilage regeneration: Focus on pathophysiology and molecular
mechanisms. Int J Mol Sci. 20(6156)2019.PubMed/NCBI View Article : Google Scholar
|
29
|
Akkiraju H and Nohe A: Role of
chondrocytes in cartilage formation, progression of osteoarthritis
and cartilage regeneration. J Dev Biol. 3:177–192. 2015.PubMed/NCBI View Article : Google Scholar
|
30
|
Hornum L, Hansen AJ, Tornehave D, Fjording
MS, Colmenero P, Wätjen IF, Søe Nielsen NH, Bliddal H and Bartels
EM: C5a and C5aR are elevated in joints of rheumatoid and psoriatic
arthritis patients, and C5aR blockade attenuates leukocyte
migration to synovial fluid. PLoS One. 12(e0189017)2017.PubMed/NCBI View Article : Google Scholar
|
31
|
Xiang Y, Sekine T, Nakamura H, Imajoh-Ohmi
S, Fukuda H, Nishioka K and Kato T: Proteomic surveillance of
autoimmunity in osteoarthritis: Identification of triosephosphate
isomerase as an autoantigen in patients with osteoarthritis.
Arthritis Rheum. 50:1511–1521. 2004.PubMed/NCBI View Article : Google Scholar
|
32
|
Takinami Y, Yoshimatsu S, Uchiumi T,
Toyosaki-Maeda T, Morita A, Ishihara T, Yamane S, Fukuda I, Okamoto
H, Numata Y, et al: Identification of potential prognostic markers
for knee osteoarthritis by serum proteomic analysis. Biomark
Insights. 8:85–95. 2013.PubMed/NCBI View Article : Google Scholar
|
33
|
Park YJ, Chung MK, Hwang D and Kim WU:
Proteomics in Rheumatoid Arthritis Research. Immune Netw.
15:177–185. 2015.PubMed/NCBI View Article : Google Scholar
|
34
|
Camafeita E, Lamas JR, Calvo E, López JA
and Fernández-Gutiérrez B: Proteomics: New insights into rheumatic
diseases. Proteomics Clin Appl. 3:226–241. 2009.PubMed/NCBI View Article : Google Scholar
|
35
|
Mun S, Lee J, Lim MK, Lee YR, Ihm C, Lee
SH and Kang HG: Development of a novel diagnostic biomarker set for
rheumatoid arthritis using a proteomics approach. BioMed Res Int.
2018(7490723)2018.PubMed/NCBI View Article : Google Scholar
|
36
|
Lee J, Mun S, Kim D, Lee YR, Sheen DH, Ihm
C, Lee SH and Kang HG: Proteomics Analysis for Verification of
Rheumatoid Arthritis Biomarker Candidates Using Multiple Reaction
Monitoring. Proteomics Clin Appl. 13(e1800011)2019.PubMed/NCBI View Article : Google Scholar
|
37
|
Tan K and Lawler J: The interaction of
Thrombospondins with extracellular matrix proteins. J Cell Commun
Signal. 3:177–187. 2009.PubMed/NCBI View Article : Google Scholar
|
38
|
Isenberg JS, Romeo MJ, Yu C, Yu CK, Nghiem
K, Monsale J, Rick ME, Wink DA, Frazier WA and Roberts DD:
Thrombospondin-1 stimulates platelet aggregation by blocking the
antithrombotic activity of nitric oxide/cGMP signaling. Blood.
111:613–623. 2008.PubMed/NCBI View Article : Google Scholar
|
39
|
Rouanne M, Adam J, Goubar A, Robin A,
Ohana C, Louvet E, Cormier J, Mercier O, Dorfmüller P, Fattal S, et
al: Osteopontin and thrombospondin-1 play opposite roles in
promoting tumor aggressiveness of primary resected non-small cell
lung cancer. BMC Cancer. 16(483)2016.PubMed/NCBI View Article : Google Scholar
|
40
|
Pinessi D, Ostano P, Borsotti P, Bello E,
Guffanti F, Bizzaro F, Frapolli R, Bani MR, Chiorino G, Taraboletti
G, et al: Expression of thrombospondin-1 by tumor cells in
patient-derived ovarian carcinoma xenografts. Connect Tissue Res.
56:355–363. 2015.PubMed/NCBI View Article : Google Scholar
|
41
|
Bender HR, Campbell GE, Aytoda P,
Mathiesen AH and Duffy DM: Thrombospondin 1 (THBS1) promotes
follicular angiogenesis, luteinization, and ovulation in primates.
Front Endocrinol (Lausanne). 10(727)2019.PubMed/NCBI View Article : Google Scholar
|
42
|
Ernens I, Bousquenaud M, Lenoir B, Devaux
Y and Wagner DR: Adenosine stimulates angiogenesis by up-regulating
production of thrombospondin-1 by macrophages. J Leukoc Biol.
97:9–18. 2015.PubMed/NCBI View Article : Google Scholar
|
43
|
Tolsma SS, Volpert OV, Good DJ, Frazier
WA, Polverini PJ and Bouck N: Peptides derived from two separate
domains of the matrix protein thrombospondin-1 have anti-angiogenic
activity. J Cell Biol. 122:497–511. 1993.PubMed/NCBI View Article : Google Scholar
|
44
|
Foulsham W, Dohlman TH, Mittal SK,
Taketani Y, Singh RB, Masli S and Dana R: Thrombospondin-1 in
ocular surface health and disease. Ocul Surf. 17:374–383.
2019.PubMed/NCBI View Article : Google Scholar
|
45
|
Lee T, Esemuede N, Sumpio BE and Gahtan V:
Thrombospondin-1 induces matrix metalloproteinase-2 activation in
vascular smooth muscle cells. J Vasc Surg. 38:147–154.
2003.PubMed/NCBI View Article : Google Scholar
|
46
|
Maumus M, Manferdini C, Toupet K, Chuchana
P, Casteilla L, Gachet M, Jorgensen C, Lisignoli G and Noël D:
Thrombospondin-1 partly mediates the cartilage protective effect of
adipose-derived mesenchymal stem cells in osteoarthritis. Front
Immunol. 8(1638)2017.PubMed/NCBI View Article : Google Scholar
|
47
|
McMorrow JP, Crean D, Gogarty M, Smyth A,
Connolly M, Cummins E, Veale D, Fearon U, Tak PP, Fitzgerald O, et
al: Tumor necrosis factor inhibition modulates thrombospondin-1
expression in human inflammatory joint disease through altered
NR4A2 activity. Am J Pathol. 183:1243–1257. 2013.PubMed/NCBI View Article : Google Scholar
|
48
|
Luo S, Li W, Wu W and Shi Q: Elevated
expression of MMP8 and MMP9 contributes to diabetic osteoarthritis
progression in a rat model. J Orthop Surg Res.
16(64)2021.PubMed/NCBI View Article : Google Scholar
|
49
|
Lioté F, Champy R, Moenner M,
Boval-Boizard B and Badet J: Elevated angiogenin levels in synovial
fluid from patients with inflammatory arthritis and secretion of
angiogenin by cultured synovial fibroblasts. Clin Exp Immunol.
132:163–168. 2003.PubMed/NCBI View Article : Google Scholar
|
50
|
Iba K, Chiba H, Yamashita T, Ishii S and
Sawada N: Phase-independent inhibition by retinoic acid of
mineralization correlated with loss of tetranectin expression in a
human osteoblastic cell line. Cell Struct Funct. 26:227–233.
2001.PubMed/NCBI View Article : Google Scholar
|
51
|
Wewer UM, Ibaraki K, Schjørring P, Durkin
ME, Young MF and Albrechtsen R: A potential role for tetranectin in
mineralization during osteogenesis. J Cell Biol. 127:1767–1775.
1994.PubMed/NCBI View Article : Google Scholar
|
52
|
Kamper EF, Kopeikina LT, Koutsoukos V and
Stavridis J: Plasma tetranectin levels and disease activity in
patients with rheumatoid arthritis. J Rheumatol. 24:262–268.
1997.PubMed/NCBI
|
53
|
Kamper EF, Kopeikina LT, Trontzas P,
Kyriazis NC, Vaiopoulos G and Stavridis J: Comparative study of
tetranectin levels in serum and synovial fluid of patients with
rheumatoid arthritis, seronegative spondylarthritis and
osteoarthritis. Clin Rheumatol. 17:318–324. 1998.PubMed/NCBI View Article : Google Scholar
|
54
|
Vincenti MP and Brinckerhoff CE: Early
response genes induced in chondrocytes stimulated with the
inflammatory cytokine interleukin-1beta. Arthritis Res. 3:381–388.
2001.PubMed/NCBI View
Article : Google Scholar
|
55
|
Sommaggio R, Pérez-Cruz M, Brokaw JL,
Máñez R and Costa C: Inhibition of complement component C5 protects
porcine chondrocytes from xenogeneic rejection. Osteoarthritis
Cartilage. 21:1958–1967. 2013.PubMed/NCBI View Article : Google Scholar
|
56
|
Wang Q, Rozelle AL, Lepus CM, Scanzello
CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM,
et al: Identification of a central role for complement in
osteoarthritis. Nat Med. 17:1674–1679. 2011.PubMed/NCBI View Article : Google Scholar
|
57
|
Silawal S, Triebel J, Bertsch T and
Schulze-Tanzil G: Osteoarthritis and the complement cascade. Clin
Med Insights Arthritis Musculoskelet Disord: Jan 3, 2018 (Epub
ahead of print). doi: 10.1177/1179544117751430.
|